FDA News Analysis
🌏 NMPAExpert commentary and market intelligence for pharma strategy teams
Showing 1–6 of 6 articles
Earlier
High impact AnalysisJun 3, 2026
Kelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide
FDA · oncology · 5 min
Dr. Yuki TanakaHigh impact AnalysisJun 3, 2026
AbbVie Secures FDA Approval for ImmunoGen's Elahere
FDA · rare blood cancers · 6 min
Dr. Yuki TanakaHigh impact AnalysisJun 2, 2026
How Medicine Forgot Women: A Missed Opportunity for Asia
9 min
Dr. Yuki TanakaHigh impact AnalysisJun 2, 2026
Shionogi's Xocova Gains FDA Clearance for COVID-19 Post-Exposure Prevention
FDA · COVID-19 · 7 min
Dr. Sarah MitchellHigh impact AnalysisJun 2, 2026
UCB's Bimzelx Triumph: Psoriatic Arthritis Market Implications and Competitive Landscape
FDA · psoriatic arthritis · 8 min
Dr. Yuki TanakaHigh impact AnalysisJun 2, 2026
CDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy
FDA · 11 min
Dr. Yuki TanakaExplore intelligence